My watch list
my.bionity.com  
Login  

Genentech

News Genentech

  • Genmab announces patent settlement agreement for ofatumumab

    Genmab A/S announced that GlaxoSmithKline (GSK) has agreed a settlement with Genentech Inc. and City of Hope (a California not-for-profit organization) concerning two U.S. patents that relate to recombinant antibody production for ofatumumab. GSK is Genmab’s development and commercial collaborator f more

  • Genentech Initiates First-in-Human Study with NovImmune’s Anti-IL17 Antibody

    NovImmune announced that Genentech, a member of the Roche Group, initiated a First-in-Human study with anti-IL-17 (NI-1401, RG7624), a fully human monoclonal antibody designed to specifically and selectively bind to the human IL-17 family of cytokines. The anti-IL-17 antibody was generated at NovImm more

  • Galapagos and Genentech extend drug discovery collaboration

    Galapagos NV announced that its service division Argenta has extended its integrated contract drug discovery agreement with Genentech, a member of the Roche Group.  Total potential value of the contract extension is up to £21.5 million (€23.4 million). This is the third such extension since the agre more

All news on genentech

Publications Genentech

All publications on genentech

Market studies Genentech

  • Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019

    Introduction GlobalData, the industry analysis specialist, has released its new report, “Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Retinal Vein Occlusion Therapeutics market. more

  • Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021

    What are the commercial prospects for the pharmacological treatment of acute coronary syndrome? Our new report shows you its revenue potential from 2011 to 2021. We predict and explain the commercial opportunities in that industry and market. Our report gives you revenue forecasts to 2021 for treat more

  • F. Hoffmann-La Roche Ltd: PharmaVitae Profile

    Introduction This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs Fea more

All market studies on genentech

Websites Genentech

Trillium Therapeutics Inc. (TTI)

Corporate Overview History Management Team Board of Directors Collaborators & Advisors Current Investors Overview Therapeutic Areas Pipeline Publications Press Releases Presentations Careers Press Releases Trillium expands immunology pipeline and enters stem cell field through in-licensing of two ne more

BioInvent > Products > Pipeline

Sitemap In English / På Svenska - Contact - We are discovering and developing innovative antibody drugs for the treatment of cancer, thrombosis, atherosclerosis and inflammatory disease. Our most advanced product has finished Phase II clinical development. Home About BioInvent Products Partners Scie more

Genizon Biosciences | Offering Statistical Genetics and Biomarker Discovery Platform

Home | Contact Us | Subscribe to our News | Site Map | Français About Genizon Management Board of Directors Ethics Advisory Committee Investors Partnering About Genizon Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging more

All websites on genentech
Definition

Genentech

Genentech Genentech Inc. (), a composite of Genetic Engineering Technology, Inc., is a leading biotechnology corporation , which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer . "Genentech was ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE